Cameron John Reynolds

Cameron John Reynolds discloses dealings in Volitionrx Ltd to SEC (Form 4). We count 43 filings; the first trade dates from 3 September 2014 and the latest from 26 February 2026.

On the open market, the record shows 8 purchases worth €55k and 2 sales worth €11k. The totals exclude 1 filing filed without an amount. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. The rest of the record consists of 25 share grants and 4 option exercises.

Half of the purchases are above €7,080 and half below. 3 out of 5 purchases came within 30 days of a purchase by at least one other insider of the same company. A cluster is several different insiders buying the same stock within a short window, a pattern studied more closely than a single purchase. Looking at 7 purchases old enough to measure, the stock rose over the following 90 days in 57% of cases; the median change was +11.6%. These figures describe past trades and do not predict future prices.

On 27 February 2026 came the latest disclosure, a share grant in Volitionrx Ltd. The last purchase on record was published on 16 August 2023, which is 1,165 days ago. The median gap between a trade and its publication by SEC (Form 4) is 2 days. The legal deadline for a Form 4 is two business days after the transaction. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.